These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neutralising antibody response to oral poliovirus vaccine after primary immunisation with inactivated poliovirus vaccine. Guérin N, Bregère P, Caudrelier P, Raynaud O. Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):815-6. PubMed ID: 9923532 [No Abstract] [Full Text] [Related]
3. The final stages of the global eradication of polio. John TJ. N Engl J Med; 2000 Sep 14; 343(11):806-7. PubMed ID: 10984572 [No Abstract] [Full Text] [Related]
6. Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman. Sutter RW, Suleiman AJ, Malankar PG, Mehta FR, Medany MA, Arif MA, Linkins RW, Pallansch MA, El-Bualy MS, Robertson SE. J Infect Dis; 1997 Feb 14; 175 Suppl 1():S235-40. PubMed ID: 9203722 [Abstract] [Full Text] [Related]
7. [The role of Sabin inactivated poliovirus vaccine in the final phase of global polio eradication]. Dong SZ, Zhu WB. Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec 06; 50(12):1032-1035. PubMed ID: 28057104 [Abstract] [Full Text] [Related]
8. Polio vaccines: WHO position paper – March, 2016. Wkly Epidemiol Rec; 2016 Mar 25; 91(12):145-68. PubMed ID: 27039410 [No Abstract] [Full Text] [Related]
11. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines. J Infect Dis; 1997 Feb 25; 175 Suppl 1():S215-27. PubMed ID: 9203720 [Abstract] [Full Text] [Related]
13. Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines. McBean AM, Thoms ML, Albrecht P, Cuthie JC, Bernier R. Am J Epidemiol; 1988 Sep 25; 128(3):615-28. PubMed ID: 2843039 [Abstract] [Full Text] [Related]
14. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine]. Moĭseieva HV, Zadorozhna VI. Lik Sprava; 2002 Sep 25; (2):85-8. PubMed ID: 12073271 [Abstract] [Full Text] [Related]
16. Comparing Israeli and Palestinian polio vaccination policies and the challenges of silent entry of wild poliovirus in 2013-14: a 'natural experiment'. Flahault A, Orenstein W, Garon J, Kew O, Bickford J, Tulchinsky T. Int J Public Health; 2015 Nov 25; 60(7):765-6. PubMed ID: 26140857 [No Abstract] [Full Text] [Related]
17. New recommendations for poliovirus vaccination. Combination regimen captures best effects of available vaccines. Conrad DA, Jenson HB. Postgrad Med; 1997 Nov 25; 102(5):45-8, 51-3, 59-60 passim. PubMed ID: 9385331 [Abstract] [Full Text] [Related]
18. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation. Duintjer Tebbens RJ, Thompson KM. J Infect Dis; 2014 Nov 01; 210 Suppl 1():S485-97. PubMed ID: 25316871 [Abstract] [Full Text] [Related]
19. Cessation of use of trivalent oral polio vaccine and introduction of inactivated poliovirus vaccine worldwide, 2016. Wkly Epidemiol Rec; 2016 Sep 09; 91(36-37):421-7. PubMed ID: 27623614 [No Abstract] [Full Text] [Related]
20. Polio endgame: the global introduction of inactivated polio vaccine. Patel M, Zipursky S, Orenstein W, Garon J, Zaffran M. Expert Rev Vaccines; 2015 May 09; 14(5):749-62. PubMed ID: 25597843 [Abstract] [Full Text] [Related] Page: [Next] [New Search]